These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7629877)

  • 41. Sentinel node biopsy: facts to clear the alleged clouds.
    Morton DL; Elashoff R
    Arch Dermatol; 2008 May; 144(5):685-6; author reply 687. PubMed ID: 18490604
    [No Abstract]   [Full Text] [Related]  

  • 42. Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology.
    Berking C; Herlyn M
    Histol Histopathol; 2001 Apr; 16(2):669-74. PubMed ID: 11332722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
    Kurdoglu M; Güllü IH; Akalin I
    Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The melanocyte and melanoma.
    Conley J
    Laryngoscope; 1990 Dec; 100(12):1310-2. PubMed ID: 2243524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Malignant melanoma, general presentation].
    Mole B
    Soins Chir; 1984; (42-43):3-6. PubMed ID: 6569628
    [No Abstract]   [Full Text] [Related]  

  • 46. [Beta-catenin and N-ras: a dangerous association for melanocytes].
    Bertolotto C
    Med Sci (Paris); 2008 Feb; 24(2):122-3. PubMed ID: 18272065
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative autoradiographic study on the stroma reaction in melanoma and basal cell epithelioma (author's transl)].
    Pullmann H; Steigleder GK
    Arch Dermatol Forsch; 1974; 250(2):173-6. PubMed ID: 4611352
    [No Abstract]   [Full Text] [Related]  

  • 48. Significance of multiple nodal basin drainage in patients with truncal melanoma.
    Ahmadzadehfar H; Hinz T; Wierzbicki A; Höller T; Habibi E; Wenzel J; Muckle M; Biersack HJ; Essler M; Schmid-Wendtner M
    Q J Nucl Med Mol Imaging; 2016 Sep; 60(3):274-9. PubMed ID: 24844255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seasonal variation in diagnosis of invasive cutaneous melanoma.
    Gefeller O; Pfahlberg A; Uter W; Radespiel-Tröger M
    Cancer Epidemiol; 2016 Feb; 40():196-7. PubMed ID: 26631450
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-invasive metabolic imaging of melanoma progression.
    Pastore MN; Studier H; Bonder CS; Roberts MS
    Exp Dermatol; 2017 Jul; 26(7):607-614. PubMed ID: 27992081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Malignant melanoma. Pathological anatomy].
    Wechsler J; Belaich S
    Rev Prat; 1993 Sep; 43(13):1743-6. PubMed ID: 8303202
    [No Abstract]   [Full Text] [Related]  

  • 52. [Spontaneous regression in malignant melanoma].
    Avinoach I
    Harefuah; 1992 May; 122(9):587-92. PubMed ID: 1526586
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of chemokines in melanoma tumor growth and metastasis.
    Payne AS; Cornelius LA
    J Invest Dermatol; 2002 Jun; 118(6):915-22. PubMed ID: 12060384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Functional activity of the thymus gland and pituitary-adrenal system in patients with malignant skin melanoma].
    Labunets IF; Vasiliuk AN
    Eksp Onkol; 1984; 6(1):63-5. PubMed ID: 6094142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aberrant lymphatic drainage from a melanoma located in epigastric area].
    Nogareda Z; Vilalta A; Benassar A; Paredes P; Vidal-Sicart S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):390-1. PubMed ID: 24721510
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hormonal function of the thymus gland in melanoma of the skin: relation to functional disorders of other endocrine glands].
    Grinevich IuA; Labunets IF
    Vopr Onkol; 1987; 33(9):21-8. PubMed ID: 3660752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein kinase C in melanoma.
    Oka M; Kikkawa U
    Cancer Metastasis Rev; 2005 Jun; 24(2):287-300. PubMed ID: 15986138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathophysiology and staging of cutaneous malignant melanoma.
    Schultz S; Mastrangelo MJ
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):27-33. PubMed ID: 2645653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EGFR activated cell mobility - A link to melanoma ulceration.
    Katunarić M; Zamolo G; Jonjić N
    Med Hypotheses; 2015 Oct; 85(4):498-9. PubMed ID: 26189002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma.
    Prehn RT
    Cancer Res; 1996 Mar; 56(5):937-940. PubMed ID: 8640780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.